These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20679044)

  • 41. Clostridium difficile enteritis following total colectomy.
    Yafi FA; Selvasekar CR; Cima RR
    Tech Coloproctol; 2008 Mar; 12(1):73-4. PubMed ID: 18524025
    [No Abstract]   [Full Text] [Related]  

  • 42. Laboratory diagnosis of antibiotic-associated diarrhea: a Polish pilot study into the clinical relevance of Clostridium difficile and Clostridium perfringens toxins.
    Pituch H; Obuch-Woszczatyński P; Wultańska D; van Belkum A; Meisel-Mikołajczyk F; Łuczak M
    Diagn Microbiol Infect Dis; 2007 May; 58(1):71-5. PubMed ID: 17300901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fulminant pseudomembranous colitis of the left colon successfully treated by surgical resection.
    Yağci G; Kaymakçioğlu N; Demiriz M; Cetiner S
    Turk J Gastroenterol; 2005 Sep; 16(3):174-7. PubMed ID: 16245233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of infections associated with Clostridium difficile].
    Szczesny A; Martirosian G
    Wiad Lek; 2003; 56(5-6):278-82. PubMed ID: 14526488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nitazoxanide versus metronidazole for Clostridium difficile-associated colitis.
    Young JD; Mangino JE; Stevenson KB; Koletar SL
    Clin Infect Dis; 2007 Jan; 44(1):152; author reply 152-4. PubMed ID: 17143841
    [No Abstract]   [Full Text] [Related]  

  • 46. Predictors of first recurrence in Clostridium difficile-associated disease. A study of 306 patients hospitalized in a Romanian tertiary referral center.
    Lupse M; Flonta M; Cioara A; Filipescu I; Todor N
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):397-403. PubMed ID: 24369321
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repeat Clostridium difficile Testing.
    Gupta A; Khanna S
    JAMA; 2016 Dec; 316(22):2422-2423. PubMed ID: 27959982
    [No Abstract]   [Full Text] [Related]  

  • 48. [Recurrent Clostridium difficile enterocolitis].
    Bergamin B; Hess T; Jost R; Ballmer PE; Imoberdorf R
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1681-4. PubMed ID: 11103440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meeting the challenge of recurrent Clostridium difficile infection.
    Johnson S
    J Hosp Med; 2012 Mar; 7 Suppl 3():S11-3. PubMed ID: 22407994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clostridium difficile pericarditis complicating pseudomembranous colitis in a trauma patient.
    Koehler R; Mone M; Kimball E; Vargo D; Lonardo N; Barton R
    J Trauma; 2003 Oct; 55(4):771-3. PubMed ID: 14566136
    [No Abstract]   [Full Text] [Related]  

  • 51. Defining surgical therapy for pseudomembranous colitis with toxic megacolon.
    Berman L; Carling T; Fitzgerald TN; Bell RL; Duffy AJ; Longo WE; Roberts KE
    J Clin Gastroenterol; 2008; 42(5):476-80. PubMed ID: 18277885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update on Clostridium difficile-induced colitis, Part 2.
    Reinke CM; Messick CR
    Am J Hosp Pharm; 1994 Aug; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Reccurent pseudomembranous colitis treated with the donor feces].
    Härkönen N
    Duodecim; 1996; 112(19):1803-4. PubMed ID: 10596179
    [No Abstract]   [Full Text] [Related]  

  • 54. Basic and clinical aspects of Clostridium difficile colitis.
    Morishita T; Nakayama T; Kamiya T; Mori S; Isobe K; Furuta Y
    Rev Gastroenterol Peru; 2004; 24(3):263-9. PubMed ID: 15483687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pseudomembranous colitis probably caused by Clostridium difficile: first case appeared during preventive treatment of infection of ascitic fluid with norfloxacin].
    Tordjman R; Benfiguig K; Eugène C; Mitry E; Merrer J
    Gastroenterol Clin Biol; 1995 May; 19(5):545-6. PubMed ID: 7590012
    [No Abstract]   [Full Text] [Related]  

  • 56. [Colitis associated with C. difficile].
    Mironov IL; Ratnikova LI; Pirogov DV; Mil'chenko IB
    Eksp Klin Gastroenterol; 2014; (11):65-8. PubMed ID: 25842668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rifaximin in the treatment of recurrent Clostridium difficile infection.
    Mattila E; Arkkila P; Mattila PS; Tarkka E; Tissari P; Anttila VJ
    Aliment Pharmacol Ther; 2013 Jan; 37(1):122-8. PubMed ID: 23095030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of rifaximin and vancomycin combination therapy in a patient with refractory Clostridium difficile-associated diarrhea.
    Berman AL
    J Clin Gastroenterol; 2007; 41(10):932-3. PubMed ID: 18090164
    [No Abstract]   [Full Text] [Related]  

  • 59. Clostridium difficile colitis: epidemiology, pathophysiology, and treatment.
    Mitty RD; Lamont JT
    Mt Sinai J Med; 1994 Sep; 61(4):329-35. PubMed ID: 7969226
    [No Abstract]   [Full Text] [Related]  

  • 60. Skin and environmental contamination with vancomycin-resistant Enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease.
    Sethi AK; Al-Nassir WN; Nerandzic MM; Donskey CJ
    Infect Control Hosp Epidemiol; 2009 Jan; 30(1):13-7. PubMed ID: 19046063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.